Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0XH9B
|
||||
Former ID |
DIB000311
|
||||
Drug Name |
Tabimorelin
|
||||
Synonyms |
NN-703; NNC-26-0703; Tabimorelin < Prop INN >; N-[5-Amino-5-methyl-2(E)-hexenoyl]-N-methyl-3-(2-naphthyl)-D-alanyl-N-methyl-D-phenylalanine methylamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Growth hormone deficiency [ICD9: 253.0, 253.3; ICD10:E22.0, E23.0] | Phase 2 | [525551] | ||
Structure |
Download2D MOL |
||||
Formula |
C32H40N4O3
|
||||
Canonical SMILES |
CNC(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@@H](Cc2ccc3ccccc3c2<br />)N(C)C(=O)\\C=C\\CC(C)(C)N
|
||||
InChI |
1S/C32H40N4O3/c1-32(2,33)19-11-16-29(37)35(4)28(22-24-17-18-25-14-9-10-15-26(25)20-24)31(39)36(5)27(30(38)34-3)21-23-12-7-6-8-13-23/h6-18,20,27-28H,19,21-22,33H2,1-5H3,(H,34,38)/b16-11+/t27-,28-/m1/s1
|
||||
InChIKey |
WURGZWOTGMLDJP-ZCYANPAGSA-N
|
||||
CAS Number |
CAS 193079-69-5
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Growth hormone secretagogue receptor type 1 | Target Info | Modulator | [525551] | |
NetPath Pathway | Leptin Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.